CJC-1295 + DAC 5mg

CJC-1295 + DAC 5mg, A synthetic peptide called CJC-1295 with DAC (5 mg) is intended to increase the activity of growth hormone-releasing hormone (GHRH). Presented in a smaller vial size for research reasons, it is virtually the same substance as the 10 mg form. There is no variation in the structure or mechanism of action, just in the quantity provided.

• The pituitary gland is stimulated to secrete growth hormone by the modified GHRH analog CJC-1295 with DAC.
• The peptide can attach to serum albumin thanks to the DAC (Drug Affinity Complex), which delays its breakdown and clearance.
• The half-life of the peptide is increased from minutes (natural GHRH) to several days by this alteration.

CJC-1295 + DAC 5mg | Characteristics

• Structure: 29 amino acids designed for stability, drawn from human GHRH.
• DAC Linker: Increases circulation time by facilitating albumin binding.
• Half-Life: 6–8 days, as opposed to minutes for natural GHRH.
• Formulation: Available in different vial sizes (e.g., 5 mg, 10 mg) for research.
• Administration: Studied in injectable form.

CJC-1295 + DAC 5mg | Impacts

• Growth hormone secretion is stimulated over an extended period of time by sustained GH release.
• Increased IGF-1: Promotes anabolic processes by raising insulin-like growth factor 1.
• Muscle Growth & Recovery: Promotes tissue healing and protein production.
• Fat Metabolism: Encourages lipolysis to help reduce fat.
• Sleep Quality: Deeper, healing sleep is associated with growth hormone release.
• Anti-Aging Potential: Promotes cellular renewal and repair.

Advantages

• Convenience: Less frequent injections are required due to the long half-life.
• Stable Hormone Levels: Instead of abrupt spikes, they mimic the normal pulsatile release of GH.
• Performance & Recovery: Promotes the growth of lean muscle and quicker recuperation.
• Fat Reduction: Promotes fat breakdown and metabolic activity.
• Therapeutic Potential: Examined for metabolic diseases, muscular atrophy, and age-related GH loss.
• Synergy: Often investigated in conjunction with other peptides, such as ipamorelin, to improve results.

Synopsis
A long-acting GHRH analog, CJC-1295 with DAC (5 mg) increases IGF-1, promotes muscle growth, fat loss, and recuperation, and maintains growth hormone secretion for days. With the same characteristics as the 10 mg version, the 5 mg vial size just represents the quantity of peptide accessible for study. Although it is still under investigation and needs to be handled carefully in laboratory settings, its long half-life and possible advantages make it an important chemical in peptide research.